The Best of the AACR Journals Collection: Author Profiles
Title & Affiliation:
Senior Vice President, Head of Research, Seagen, Bothell, WA.
Preclinical Activity of HER2-Selective Tyrosine Kinase Inhibitor Tucatinib as a Single Agent or in Combination with Trastuzumab or Docetaxel in Solid Tumor Models
Q: What is your primary area of study/research?
A: Cancer drug discovery.
Q: What influenced your decision to embark on a research career?
A: Natural curiosity, interest in understanding mechanistic biology, biochemistry, and molecular biology, and a passion for directing my research toward identifying innovative drugs to help cancer patients.
Q; What excites you most about your research area?
A: The potential to help patients with cancers. Being able to translate new concepts into drugs that may improve the lives of cancer patients is an incredible privilege.
Q: What do you do for fun outside of work? What are your passions and hobbies?
A: Fly fishing and hiking.
Read The Best of the AACR Journals
See the rest of the authors featured in The Best of the AACR Journals Collection for 2022